An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

NCT00206336 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: Topiramate (drug)

Sponsor

Baylor College of Medicine

Collaborators

[object Object]